21 CFR Part 601
LICENSING
June 25, 2020
Subpart
D
Diagnostic Radiopharmaceuticals
Subpart
A
General Provisions
Subpart
B
[Reserved]
Subpart
C
Biologics Licensing
Subpart
E
Accelerated Approval of Biological Products for Serious or Life-Threatening Illnesses
Subpart
F
Confidentiality of Information
Subpart
G
Postmarketing Studies
Subpart
H
Approval of Biological Products When Human Efficacy Studies Are Not Ethical or Feasible
Tried the LawStack mobile app?
Join thousands and try LawStack mobile for FREE today.
- Carry the law offline, wherever you go.
- Download CFR, USC, rules, and state law to your mobile device.
